Prevalence of molecular and serological tests of the new coronavirus (SARS-CoV-2) in Carlos Chagas laboratory – Sabin group in Cuiabá

Autor: Cristiane Coimbra de Paula, Walkiria Shimoya-Bittencourt, João Pedro Castoldo Passos, Caroline Aquino Vieira De Lamare Paula, Karuppusamy Arunachalam, Cor Jesus Fernandes Fontes, Ruberlei Godinho de Oliveira

Publikováno v: Revista da Associação Médica Brasileira, Volume: 68, Issue: 3, Pages: 344-350, Published: 15 APR 2022
Revista da Associação Médica Brasileira v.68 n.3 2022
Revista da Associação Médica Brasileira
Associação Médica Brasileira (AMB)
instacron:AMB

SUMMARY BACKGROUND: Coronavirus disease 2019, which is caused by the new severe acute respiratory syndrome coronavirus 2, became a pandemic in 2020 with a mortality rate of 2% and high transmissibility, thus making studies with an epidemiological pro

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3791814f639439a2e6a44263a27b80b4
https://doi.org/10.1590/1806-9282.20210769